Cover Image

Are adipocytokines inflammatory or metabolic mediators in patients with inflammatory bowel disease?

Resul Kahraman,1 Turan Calhan,1 Abdurrahman Sahin,1 Kamil Ozdil,1 Zuhal Caliskan,1 Elif Sinem Bireller,2 Bedia Cakmakoglu3 1Department of Gastroenterology, Umraniye Education and Training Hospital, Health Sciences University, 2Department of Pharmaceutical Microbiology, Faculty of Pharmacy, Istanbul...

Full description

Saved in:

Bibliographic Details
Main Authors:	Kahraman R (Author), Calhan T (Author), Sahin A (Author), Ozdil K (Author), Caliskan Z (Author), Bireller ES (Author), Cakmakoglu B (Author)
Format:	Book
Published:	Dove Medical Press, 2017-09-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

The relationship between statin therapy and adipocytokine/inflammatory mediators in dyslipidemic nondiabetic patients: A comparative study
by: Hany A. Al-hussaniy, et al.
Published: (2023)

The role of adipocytokines and endothelial dysfunction with irritable bowel syndrome associated with obesity
by: Yu. Bilooka, et al.
Published: (2021)

Metabolic network of the gut microbiota in inflammatory bowel disease
by: Kohei Sugihara, et al.
Published: (2024)

Inflammatory Bowel Disease
by: David B. Sachar, et al.
Published: (2012)

Linear growth and bone metabolism in pediatric patients with inflammatory bowel disease
by: Paloma Velez de Andrade Lima Simões Ferreira, et al.
Published: (2019)

Linear growth and bone metabolism in pediatric patients with inflammatory bowel disease
by: Paloma Velez de Andrade Lima Simões Ferreira, et al.
Published: (2019)

Impact of child obesity on adipose tissue physiology: assessment of adipocytokines and inflammatory cytokines as biomarkers of obesity
by: Maria Chiara Leoni, et al.
Published: (2010)

Pathology of Inflammatory Bowel Disease
by: Shiva Raj K.C
Published: (2015)

The Bowel Microbiota and Inflammatory Bowel Diseases
by: Gerald W. Tannock
Published: (2010)

Inflammatory Bowel Disease
Published: (2012)

The puzzling inflammatory bowel disease: growing interest for mediators of inflammation
by: F. J. Zijlstra
Published: (1997)

Metalloproteinases in Inflammatory Bowel Diseases
by: Marônek M, et al.
Published: (2021)

Inflammatory arthritis associated with inflammatory bowel disease in children
by: Desgranges M, et al.
Published: (2008)

Metabolic regulation of the Th17/Treg balance in inflammatory bowel disease
by: Shunfen Zhang, et al.
Published: (2024)

New Frontiers in Therapeutic Drug Monitoring of Biologics in Inflammatory Bowel Disease and Other Immune-Mediated Inflammatory Diseases
Published: (2023)

Immune-mediated disease units: A step forward for patients with inflammatory bowel disease
by: Esther Chamorro-, et al.
Published: (2022)

Understanding and targeting centrally mediated visceral pain in inflammatory bowel disease
by: Kristen Elise Farrell, et al.
Published: (2014)

Anemia in Inflammatory Bowel Disease: A Neglected Issue in Comprehensive Inflammatory Bowel Disease Management
by: Randy Adiwinata, et al.
Published: (2021)

Inflammatory bowel disease in children
by: Maciej Putowski, et al.
Published: (2019)

Inflammatory bowel disease in children
by: Maciej Putowski, et al.
Published: (2019)

Infliximab in inflammatory bowel disease
by: Konstantinos Papamichael, et al.
Published: (2019)

Bacteriotherapy for inflammatory bowel disease
by: Yusuke Yoshimatsu, et al.
Published: (2021)

Somatostatin in inflammatory bowel disease
by: J. D. Van Bergeijk, et al.
Published: (1997)

Angiogenesis in Inflammatory Bowel Disease
by: Canan Alkim, et al.
Published: (2015)

Cytokines in inflammatory bowel disease
by: P. L. Beck, et al.
Published: (1997)

The Effect of Pregnancy and Inflammatory Bowel Disease on the Pharmacokinetics of Drugs Related to Inflammatory Bowel Disease-A Systematic Literature Review
by: Thomas K. Wiersma, et al.
Published: (2022)

Anemia in Inflammatory Bowel Diseases in Children
by: A. O. Anushenko, et al.
Published: (2016)

COMPLIANCE AND QUALITY OF LIFE OF PATIENTS WITH INFLAMMATORY BOWEL DISEASES
by: R.J. JAMOLOVA, et al.
Published: (2024)

Inflammatory Bowel Disease Advances in Pathogenesis and Management
Published: (2012)

Circulating levels of the adipocytokines vaspin and omentin in patients with Kawasaki disease
by: Galeazzi M, et al.
Published: (2011)

Relationship between insulin resistance and adipocytokines: the mediator role of adiposity in children
by: Caroline Brand, et al.
Published: (2020)

Metabolic Host-Microbiota Interactions in Autophagy and the Pathogenesis of Inflammatory Bowel Disease (IBD)
by: Alexander S. Dowdell, et al.
Published: (2021)

Tryptophan Metabolism, Regulatory T Cells, and Inflammatory Bowel Disease: A Mini Review
by: Xueyan Ding, et al.
Published: (2020)

Recent Progress in the Diagnosis and Precise Nanocarrier-Mediated Therapy of Inflammatory Bowel Disease
by: Wang L, et al.
Published: (2021)

Antidiabetic activity of Berberis brandisiana is possibly mediated through modulation of insulin signaling pathway, inflammatory cytokines and adipocytokines in high fat diet and streptozotocin-administered rats
by: Shumaila Mehdi, et al.
Published: (2023)

Leukocyte migration in experimental inflammatory bowel disease
by: E. P. Van Rees, et al.
Published: (1997)

Non Steroidal Anti-Inflammatory Drugs and Inflammatory Bowel Disease
by: Amir Klein, et al.
Published: (2010)

Inflammatory bowel disease: the role of inflammatory cytokine gene polymorphisms
by: Joanna Balding, et al.
Published: (2004)

Eating habits in patients with inflammatory bowel disease
by: Aleksandra Iwona Zimna, et al.
Published: (2021)

Managing inflammatory bowel disease in adolescent patients
by: Bishop J, et al.
Published: (2014)